Drug shortages, threat to public health persists, despite actions to help maintain product availability : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives / statement of Marcia Crosse.

Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.
Published: (2012)

Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.
Published: (2012)

Drug shortages : FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate
by: Crosse, Marcia
Published: (2011)

Economic analysis of the causes of drug shortages.
Published: (2011)

Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011.
Published: (2014)

Drug shortages, certain factors are strongly associated with this persistent public health challenge : report to congressional committee.
Published: (2016)

Availability of internationally controlled drugs : ensuring adequate access for medical and scientific purposes : indispensable, adequately available and not unduly restricted
Published: (2016)

Drug shortages : causes, FDA authority, and policy options
by: Bodie, Agata
Published: (2018)

Examining the increase in drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 23, 2011.
Published: (2013)

Examining the increase in drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 23, 2011.
Published: (2013)

Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014.
Published: (2014)

Recent developments which may impact consumer access to, and demand for, pharmaceuticals hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.
Published: (2001)

Guide to drug financing mechanisms
Published: (1998)

Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012.
Published: (2013)

Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012.
Published: (2013)

Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014.
Published: (2014)

Drug shortages : FDA's ability to respond should be strengthened : report to congressional requesters.
Published: (2011)

Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
by: Crosse, Marcia
Published: (2007)

Seniors' access to affordable prescription drugs models for reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, February 16, 2000.
Published: (2000)

Drug Shortages Threat To Public Health Persists Despite Actions To Help Maintain Product Availability
Published: (2014)

Reimbursement and access to prescription drugs under Medicare part B hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002.
Published: (2002)

Medicare payments for newly available generic drugs.
Published: (2011)

The truth about the drug companies : how they deceive us and what to do about it
by: Angell, Marcia
Published: (2004)

Drug development
Published: (1982)

Entry threats and pricing in the generic drug industry
by: Wendling, Brett
Published: (2010)

The clinical role of the community pharmacist
Published: (1990)

Drug safety : FDA faces challenges overseeing the foreign drug manufacturing supply chain : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate
by: Crosse, Marcia
Published: (2011)

Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
by: Crosse, Marcia
Published: (2007)

Medicines for man ; the development, regulation, and use of prescription drugs
by: Dowling, Harry F. (Harry Filmore), 1904-2000
Published: (1970)

Generic drugs the pay-for-delay problem
Published: (2011)

Drug safety : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives
by: Crosse, Marcia
Published: (2007)

Drugs@FDA.

Pharmaceutical chemicals in perspective
by: Reuben, Bryan G., 1934-2012
Published: (1989)

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Published: (2013)

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Published: (2013)

Drug safety : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives
by: Crosse, Marcia
Published: (2008)